Non-Small Cell Lung Cancer

When you come to us for diagnosis or treatment for non-small cell lung cancer, you can typically see each member of our group on the same day. Your team may include pulmonologists, thoracic surgeons, medical oncologists, radiation oncologists, and interventional radiologists. This multidisciplinary team of internationally renowned experts creates a treatment plan that’s customized for you.

We use a variety of tests on tissue and blood to learn as much about the lung cancer as possible, helping us create the best treatment plan for you.

Our clinical trials can provide the newest therapeutic options, such as targeted drugs and immunotherapy. We also offer many supportive services, such as lung rehabilitation, psychological care, and integrative health therapies.

Clinical Trials and Research Studies

Phase 2

The Selective Personalized Radio-Immunotherapy for locally advanced NSCLC Trial (SPRINT)

Learn More

Phase 3

Phase III randomized double-blind placebo-controlled multi-centre study assessing the efficacy and safety of durvalumab versus placebo as treatment following SBRT in patients with Stage I/II non small cell lung cancer.

Learn More

Phase 1/2

A Phase 1/2 Open-Label Multi-Center First-in-Human Study of the Safety Tolerability Pharmacokinetics and Anti-Tumor Activity of TPX-0005 in Patients with Advanced Solid Tumors Harboring ALK ROS1 or NTRK1-3 Rearrangements (TRIDENT-1)

Learn More

Phase 1

A Phase 1/1b Open-Label Multi-Center Study to Characterize the Safety and Tolerability of TRQ15-01 in Patients with Relapsed/Refractory Solid Tumors and Lymphomas

Learn More